Mouse models of graft-versus-host disease: advances and limitations

por Schroeder, Mark A., DiPersio, John F.
Publicado 2011

Insights into the role of the JAK/STAT signaling pathway in graft-versus-host disease

por Abboud, Ramzi, Choi, Jaebok, Ruminski, Peter, Schroeder, Mark A., Kim, Sena, Abboud, Camille N., DiPersio, John F.
Publicado 2020

Oncolytic measles virus strains have significant antitumor activity against glioma stem cells

por Allen, Cory, Opyrchal, Mateusz, Aderca, Ileana, Schroeder, Mark A., Sarkaria, Jann N., Domingo, Evidio, Federspiel, Mark J., Galanis, Evanthia
Publicado 2012

A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease

por Pratta, Michael, Paczesny, Sophie, Socie, Gerard, Barkey, Natalie, Liu, Hao, Owens, Sherry, Arbushites, Michael C., Schroeder, Mark A., Howell, Michael D.
Publicado 2022

The Association of Agent Orange (AO) Exposure with Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma (MM) Progression: A Population-based Study of Vietn...

por Liu, Lawrence W., Wang, Mei, Grandhi, Nikhil, Schroeder, Mark A., Thomas, Theodore, Vargo, Kristin, Gao, Feng, Sanfilippo, Kristen M., Chang, Su-Hsin
Publicado 2023

Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion

por Huveldt, Deborah, Lewis-Tuffin, Laura J., Carlson, Brett L., Schroeder, Mark A., Rodriguez, Fausto, Giannini, Caterina, Galanis, Evanthia, Sarkaria, Jann N., Anastasiadis, Panos Z.
Publicado 2013

The Role of Factor Inhibiting HIF (FIH-1) in Inhibiting HIF-1 Transcriptional Activity in Glioblastoma Multiforme

por Wang, Enfeng, Zhang, Chunyang, Polavaram, Navatha, Liu, Fengming, Wu, Gang, Schroeder, Mark A., Lau, Julie S., Mukhopadhyay, Debabrata, Jiang, Shi-Wen, O'Neill, Brian Patrick, Datta, Kaustubh, Li, Jinping
Publicado 2014

Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues

por Zhou, Dan, Alver, Bonnie M., Li, Shuang, Hlady, Ryan A., Thompson, Joyce J., Schroeder, Mark A., Lee, Jeong-Heon, Qiu, Jingxin, Schwartz, Philip H., Sarkaria, Jann N., Robertson, Keith D.
Publicado 2018

A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease

por Fløisand, Yngvar, Schroeder, Mark A., Chevallier, Patrice, Selleslag, Dominik, Devine, Steven, Renteria, Anne S., Mohty, Mohamad, Yakoub-Agha, Ibrahim, Chen, Chunlin, Parfionovas, Andrejus, Quadri, Syed, Jansson, Johan, Akbari, Mona, Chen, Yi-Bin
Publicado 2021

Machine learning–based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors

por Xiang, Jingyu, Shi, Min, Fiala, Mark A., Gao, Feng, Rettig, Michael P., Uy, Geoffrey L., Schroeder, Mark A., Weilbaecher, Katherine N., Stockerl-Goldstein, Keith E., Mollah, Shamim, DiPersio, John F.
Publicado 2022

Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease

por Choi, Jaebok, Cooper, Matthew L., Staser, Karl, Ashami, Kidist, Vij, Kiran R., Wang, Bing, Marsala, Lynne, Niswonger, Jessica, Ritchey, Julie, Alahmari, Bader, Achilefu, Samuel, Tsunoda, Ikuo, Schroeder, Mark A., DiPersio, John F.
Publicado 2018

Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high‐risk MDS: Phase 2 study results

por Cortes, Jorge E., Douglas Smith, B., Wang, Eunice S., Merchant, Akil, Oehler, Vivian G., Arellano, Martha, DeAngelo, Daniel J., Pollyea, Daniel A., Sekeres, Mikkael A., Robak, Tadeusz, Ma, Weidong Wendy, Zeremski, Mirjana, Naveed Shaik, M., Douglas Laird, A., O'Connell, Ashleigh, Chan, Geoffrey, Schroeder, Mark A.
Publicado 2018

Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10‐day decitabine regimen

por Ali, Alaa M., Weisel, Daniel, Gao, Feng, Uy, Geoffrey L., Cashen, Amanda F., Jacoby, Meagan A., Wartman, Lukas D., Ghobadi, Armin, Pusic, Iskra, Romee, Rizwan, Fehniger, Todd A., Stockerl‐Goldstein, Keith E., Vij, Ravi, Oh, Stephen T., Abboud, Camille N., Schroeder, Mark A., Westervelt, Peter, DiPersio, John F., Welch, John S.
Publicado 2017

Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy

por Ferraro, Francesca, Gruszczynska, Agata, Ruzinova, Marianna B., Miller, Christopher A., Percival, Mary Elizabeth, Uy, Geoffrey L., Pusic, Iskra, Jacoby, Meagan A., Christopher, Mathew J., Kim, Miriam Y., Westervelt, Peter, Cashen, Amanda F., Schroeder, Mark A., DiPersio, John F., Abboud, Camille N., Wartman, Lukas D., Gao, Feng, Link, Daniel C., Ley, Timothy J., Welch, John S.
Publicado 2022

Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia

por Barnell, Erica K., Newcomer, Kenneth F., Skidmore, Zachary L., Krysiak, Kilannin, Anderson, Sydney R., Wartman, Lukas D., Oh, Stephen T., Welch, John S., Stockerl-Goldstein, Keith E., Vij, Ravi, Cashen, Amanda F., Pusic, Iskra, Westervelt, Peter, Abboud, Camille N., Ghobadi, Armin, Uy, Geoffrey L., Schroeder, Mark A., Dipersio, John F., Politi, Mary C., Spencer, David H., Duncavage, Eric J., Ley, Timothy J., Griffith, Malachi, Jacoby, Meagan A., Griffith, Obi L.
Publicado 2021

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial

por Crees, Zachary D., Rettig, Michael P., Jayasinghe, Reyka G., Stockerl-Goldstein, Keith, Larson, Sarah M., Arpad, Illes, Milone, Giulio A., Martino, Massimo, Stiff, Patrick, Sborov, Douglas, Pereira, Denise, Micallef, Ivana, Moreno-Jiménez, Gemma, Mikala, Gabor, Coronel, Maria Liz Paciello, Holtick, Udo, Hiemenz, John, Qazilbash, Muzaffar H., Hardy, Nancy, Latif, Tahir, García-Cadenas, Irene, Vainstein-Haras, Abi, Sorani, Ella, Gliko-Kabir, Irit, Goldstein, Inbal, Ickowicz, Debby, Shemesh-Darvish, Liron, Kadosh, Shaul, Gao, Feng, Schroeder, Mark A., Vij, Ravi, DiPersio, John F.
Publicado 2023